A detailed history of Center For Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Center For Asset Management LLC holds 646 shares of LLY stock, worth $519,784. This represents 0.41% of its overall portfolio holdings.

Number of Shares
646
Previous 645 0.16%
Holding current value
$519,784
Previous $375,000 33.87%
% of portfolio
0.41%
Previous 0.34%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 0.16%
646 $502,000
Q4 2023

Jan 22, 2024

SELL
$525.19 - $619.13 $8,928 - $10,525
-17 Reduced 2.57%
645 $375,000
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $434 - $599
1 Added 0.15%
662 $355,000
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $27,357 - $36,580
78 Added 13.38%
661 $309,000
Q1 2023

Apr 24, 2023

BUY
$310.63 - $364.82 $621 - $729
2 Added 0.34%
583 $200,000
Q4 2022

Jan 23, 2023

SELL
$321.55 - $374.67 $97,108 - $113,150
-302 Reduced 34.2%
581 $0
Q3 2022

Oct 21, 2022

SELL
$296.48 - $337.87 $296 - $337
-1 Reduced 0.11%
883 $286,000
Q2 2022

Jul 20, 2022

SELL
$278.73 - $327.27 $119,853 - $140,726
-430 Reduced 32.72%
884 $287,000
Q1 2022

Apr 26, 2022

BUY
$234.69 - $291.66 $19,713 - $24,499
84 Added 6.83%
1,314 $376,000
Q4 2021

Jan 12, 2022

BUY
$224.85 - $279.04 $49,916 - $61,946
222 Added 22.02%
1,230 $340,000
Q3 2021

Nov 01, 2021

SELL
$221.6 - $272.71 $4,432 - $5,454
-20 Reduced 1.95%
1,008 $233,000
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $50,192 - $64,924
-278 Reduced 21.29%
1,028 $236,000
Q1 2021

Apr 28, 2021

SELL
$164.32 - $212.72 $93,005 - $120,399
-566 Reduced 30.24%
1,306 $244,000
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $244,221 - $323,163
1,872 New
1,872 $316,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Center For Asset Management LLC Portfolio

Follow Center For Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center For Asset Management LLC with notifications on news.